Cargando…

Long-term follow-up after surgery in localized laryngeal amyloidosis

To study effectiveness of surgery and watchful waiting in localized laryngeal amyloidosis, retrospective case series. This retrospective study comprises all consecutive patients with localized laryngeal amyloidosis surgically treated in a tertiary hospital between 1994 and February 2016. Recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazenberg, Aldert J. C., Hazenberg, Bouke P. C., Dikkers, Frederik G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974288/
https://www.ncbi.nlm.nih.gov/pubmed/27156084
http://dx.doi.org/10.1007/s00405-016-4061-y
_version_ 1782446525956227072
author Hazenberg, Aldert J. C.
Hazenberg, Bouke P. C.
Dikkers, Frederik G.
author_facet Hazenberg, Aldert J. C.
Hazenberg, Bouke P. C.
Dikkers, Frederik G.
author_sort Hazenberg, Aldert J. C.
collection PubMed
description To study effectiveness of surgery and watchful waiting in localized laryngeal amyloidosis, retrospective case series. This retrospective study comprises all consecutive patients with localized laryngeal amyloidosis surgically treated in a tertiary hospital between 1994 and February 2016. Recurrence rate, revision surgery, progression to systemic amyloidosis, and changes in voice were monitored yearly. Eighteen patients were included. Seven women and eleven men had a median age 50 years (range 21–77 years) and median follow-up 6.4 years (2.4–17 years). Amyloid was located in subglottis (5), glottis (8), false vocal folds (8) and other supraglottic areas (5), in more than one laryngeal region (13) and bilaterally (12). Cold steel excision was used at the glottis; CO(2) laser excision, sometimes assisted by microdebrider, at other laryngeal areas. Eleven patients needed revision surgery, ten within the first 4 years after surgical treatment. One patient needed his first revision surgery after 11 years. Five patients needed a second revision within 6 years after initial diagnosis. Two patients needed a third revision. Indications for first revision surgery were progression (8) with dysphonia (7), dyspnea (2), dysphagia (1), exclusion of malignancy (1), and aphonia (1). No patient developed systemic amyloidosis during follow-up. Although local progression of amyloid necessitates revision surgery once or twice in the first 4–6 years, progression slows down thereafter. Late progression, however, remains possible.
format Online
Article
Text
id pubmed-4974288
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49742882016-08-17 Long-term follow-up after surgery in localized laryngeal amyloidosis Hazenberg, Aldert J. C. Hazenberg, Bouke P. C. Dikkers, Frederik G. Eur Arch Otorhinolaryngol Laryngology To study effectiveness of surgery and watchful waiting in localized laryngeal amyloidosis, retrospective case series. This retrospective study comprises all consecutive patients with localized laryngeal amyloidosis surgically treated in a tertiary hospital between 1994 and February 2016. Recurrence rate, revision surgery, progression to systemic amyloidosis, and changes in voice were monitored yearly. Eighteen patients were included. Seven women and eleven men had a median age 50 years (range 21–77 years) and median follow-up 6.4 years (2.4–17 years). Amyloid was located in subglottis (5), glottis (8), false vocal folds (8) and other supraglottic areas (5), in more than one laryngeal region (13) and bilaterally (12). Cold steel excision was used at the glottis; CO(2) laser excision, sometimes assisted by microdebrider, at other laryngeal areas. Eleven patients needed revision surgery, ten within the first 4 years after surgical treatment. One patient needed his first revision surgery after 11 years. Five patients needed a second revision within 6 years after initial diagnosis. Two patients needed a third revision. Indications for first revision surgery were progression (8) with dysphonia (7), dyspnea (2), dysphagia (1), exclusion of malignancy (1), and aphonia (1). No patient developed systemic amyloidosis during follow-up. Although local progression of amyloid necessitates revision surgery once or twice in the first 4–6 years, progression slows down thereafter. Late progression, however, remains possible. Springer Berlin Heidelberg 2016-05-07 2016 /pmc/articles/PMC4974288/ /pubmed/27156084 http://dx.doi.org/10.1007/s00405-016-4061-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Laryngology
Hazenberg, Aldert J. C.
Hazenberg, Bouke P. C.
Dikkers, Frederik G.
Long-term follow-up after surgery in localized laryngeal amyloidosis
title Long-term follow-up after surgery in localized laryngeal amyloidosis
title_full Long-term follow-up after surgery in localized laryngeal amyloidosis
title_fullStr Long-term follow-up after surgery in localized laryngeal amyloidosis
title_full_unstemmed Long-term follow-up after surgery in localized laryngeal amyloidosis
title_short Long-term follow-up after surgery in localized laryngeal amyloidosis
title_sort long-term follow-up after surgery in localized laryngeal amyloidosis
topic Laryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974288/
https://www.ncbi.nlm.nih.gov/pubmed/27156084
http://dx.doi.org/10.1007/s00405-016-4061-y
work_keys_str_mv AT hazenbergaldertjc longtermfollowupaftersurgeryinlocalizedlaryngealamyloidosis
AT hazenbergboukepc longtermfollowupaftersurgeryinlocalizedlaryngealamyloidosis
AT dikkersfrederikg longtermfollowupaftersurgeryinlocalizedlaryngealamyloidosis